Published in Neuropsychopharmacology on January 01, 2002
The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci (2006) 1.10
Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference. Neuropsychopharmacology (2007) 0.82
Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine. Psychopharmacology (Berl) (2011) 0.81
Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. Behav Sci (Basel) (2014) 0.79
Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine. Pharmacol Biochem Behav (2014) 0.78
Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats. Psychopharmacology (Berl) (2003) 0.78
Localization of the brainstem GABAergic neurons controlling paradoxical (REM) sleep. PLoS One (2009) 1.31
Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study. Eur J Neurosci (2007) 1.08
Dopaminergic transmission in STOP null mice. J Neurochem (2005) 1.06
Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology (2005) 1.06
Evidence that neurons of the sublaterodorsal tegmental nucleus triggering paradoxical (REM) sleep are glutamatergic. Sleep (2011) 1.04
High temporal resolution for in vivo monitoring of neurotransmitters in awake epileptic rats using brain microdialysis and capillary electrophoresis with laser-induced fluorescence detection. J Neurosci Methods (2004) 1.02
A very large number of GABAergic neurons are activated in the tuberal hypothalamus during paradoxical (REM) sleep hypersomnia. PLoS One (2010) 1.00
Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology (2011) 0.97
5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect (2007) 0.92
Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization. Neuropsychopharmacology (2005) 0.90
In vivo simultaneous monitoring of gamma-aminobutyric acid, glutamate, and L-aspartate using brain microdialysis and capillary electrophoresis with laser-induced fluorescence detection: Analytical developments and in vitro/in vivo validations. Electrophoresis (2003) 0.90
A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance? Mol Neurobiol (2011) 0.88
Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates. Peptides (2006) 0.87
Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem Int (2005) 0.87
Enhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortex. PLoS One (2012) 0.86
Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neurosci Lett (2006) 0.86
Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area. Eur J Neurosci (2006) 0.86
Analysis of serotonin in brain microdialysates using capillary electrophoresis and native laser-induced fluorescence detection. Electrophoresis (2005) 0.86
The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anesthetic-free rat. J Neurosci (2002) 0.85
Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice. J Neurochem (2004) 0.83
Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.82
In-capillary derivatization and capillary electrophoresis separation of amino acid neurotransmitters from brain microdialysis samples. J Chromatogr A (2008) 0.82
Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference. Neuropsychopharmacology (2007) 0.82
Therapeutic potential of 5-HT7 receptors in mood disorders. Curr Drug Targets (2009) 0.81
Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis. Int J Neuropsychopharmacol (2005) 0.81
R-citalopram prevents the neuronal adaptive changes induced by escitalopram. Neuroreport (2007) 0.80
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.80
Simultaneous determination of vigabatrin and amino acid neurotransmitters in brain microdialysates by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.80
Analytical validation of microdialysis analyzer for monitoring glucose, lactate and pyruvate in cerebral microdialysates. Clin Chim Acta (2010) 0.80
Astrocytes and gliotransmitters: new players in the treatment of major depression? Curr Drug Targets (2013) 0.80
Microdialysis monitoring of catecholamines and excitatory amino acids in the rat and mouse brain: recent developments based on capillary electrophoresis with laser-induced fluorescence detection--a mini-review. Cell Mol Neurobiol (2003) 0.79
Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus. Neurobiol Aging (2009) 0.78
Long-term prenatal hypoxia alters maturation of brain catecholaminergic systems and motor behavior in rats. Synapse (2004) 0.78
Ultra high performance liquid chromatography as a tool for the discovery and the analysis of biomarkers of diseases: a review. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.78
Highly sensitive assay for the measurement of serotonin in microdialysates using capillary high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.78
Assessment of jugular blood oxygen and lactate indices for detection of cerebral ischemia and prognosis. J Neurosurg Anesthesiol (2004) 0.78
Outcome of poor-grade subarachnoid hemorrhage as determined by biomarkers of glucose cerebral metabolism. Neurocrit Care (2013) 0.78
Changes in Proenkephalin mRNA expression in forebrain areas after amphetamine-induced behavioural sensitization. Pharmacol Biochem Behav (2007) 0.77
In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. Eur J Pharmacol (2003) 0.77
A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus. J Nucl Med (2003) 0.77
Biochemical neuromonitoring of poor-grade aneurysmal subarachnoid hemorrhage: comparative analysis of metabolic events detected by cerebral microdialysis and by retrograde jugular vein catheterization. Neurol Res (2015) 0.77
In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system. Int J Neuropsychopharmacol (2004) 0.76
NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal. Neuroreport (2002) 0.76
Glutamate and aspartate do not exhibit the same changes in their extracellular concentrations in the rat striatum after N-methyl-D-aspartate local administration. J Neurosci Res (2003) 0.76
Capillary electrophoresis combined with microdialysis in the human spinal cord: a new tool for monitoring rapid peroperative changes in amino acid neurotransmitters within the dorsal horn. Electrophoresis (2004) 0.75
In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity. Synapse (2011) 0.75
Enhanced tail pinch-induced activation of catecholamine metabolism in the pericerulean area of RU 24722-treated rats. Brain Res (2004) 0.75